Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linong Ji

Showing results (551-560 of 589) with videos related to

Pageof 59
Sort By:
Chinese Medical Journal|April 3, 2025
Identification of novel pathogenic variants in genes related to pancreatic β cell function: A multi-center study in Chinese with young-onset diabetesFan Yu, Yinfang Tu, Yanfang Zhang, et al.
Diabetes, Obesity & Metabolism|December 12, 2017
Comparative effectiveness of metformin monotherapy in extended release and immediate release formulations for the treatment of type 2 diabetes in treatment-naïve Chinese patients: Analysis of results from the CONSENT trialLinong Ji, Jing Liu, Jing Yang, et al.
Diabetes Care|November 9, 2023
Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 TrialBo Zhang, Zhifeng Cheng, Ji Chen, et al.
Plos One|May 4, 2019
Prevalence of thyroid dysfunction in older Chinese patients with type 2 diabetes-A multicenter cross-sectional observational study across ChinaYu Zhu, Fengmei Xu, Jie Shen, et al.
The American Journal of Clinical Nutrition|January 27, 2017
Longitudinal association between fasting blood glucose concentrations and first stroke in hypertensive adults in China: effect of folic acid interventionRichard B Xu, Xiangyi Kong, Benjamin P Xu, et al.
Signal Transduction and Targeted Therapy|June 6, 2024
Real-world effectiveness of early insulin therapy on the incidence of cardiovascular events in newly diagnosed type 2 diabetesSihui Luo, Xueying Zheng, Wei Bao, et al.
The Lancet. Diabetes & Endocrinology|July 6, 2023
Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trialLihui Zhang, Yunliang Zhang, Sheng'ai Shen, et al.
Diabetes, Obesity & Metabolism|November 25, 2018
Identification of autoimmune type 1 diabetes and multiple organ-specific autoantibodies in adult-onset non-insulin-requiring diabetes in China: A population-based multicentre nationwide surveyYufei Xiang, Gan Huang, Yaxi Zhu, et al.
Diabetologia|December 14, 2020
Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analysesNatalie Nanayakkara, Andrea J Curtis, Stephane Heritier, et al.
The Lancet. Diabetes & Endocrinology|June 24, 2025
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialLinong Ji, Leili Gao, Haibo Xue, et al.
Pageof 59

Showing results (551-560 of 589) with videos related to

Sort By:
Pageof 59
Chinese Medical Journal|April 3, 2025
Identification of novel pathogenic variants in genes related to pancreatic β cell function: A multi-center study in Chinese with young-onset diabetesFan Yu, Yinfang Tu, Yanfang Zhang, et al.
Diabetes, Obesity & Metabolism|December 12, 2017
Comparative effectiveness of metformin monotherapy in extended release and immediate release formulations for the treatment of type 2 diabetes in treatment-naïve Chinese patients: Analysis of results from the CONSENT trialLinong Ji, Jing Liu, Jing Yang, et al.
Diabetes Care|November 9, 2023
Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 TrialBo Zhang, Zhifeng Cheng, Ji Chen, et al.
Plos One|May 4, 2019
Prevalence of thyroid dysfunction in older Chinese patients with type 2 diabetes-A multicenter cross-sectional observational study across ChinaYu Zhu, Fengmei Xu, Jie Shen, et al.
The American Journal of Clinical Nutrition|January 27, 2017
Longitudinal association between fasting blood glucose concentrations and first stroke in hypertensive adults in China: effect of folic acid interventionRichard B Xu, Xiangyi Kong, Benjamin P Xu, et al.
Signal Transduction and Targeted Therapy|June 6, 2024
Real-world effectiveness of early insulin therapy on the incidence of cardiovascular events in newly diagnosed type 2 diabetesSihui Luo, Xueying Zheng, Wei Bao, et al.
The Lancet. Diabetes & Endocrinology|July 6, 2023
Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trialLihui Zhang, Yunliang Zhang, Sheng'ai Shen, et al.
Diabetes, Obesity & Metabolism|November 25, 2018
Identification of autoimmune type 1 diabetes and multiple organ-specific autoantibodies in adult-onset non-insulin-requiring diabetes in China: A population-based multicentre nationwide surveyYufei Xiang, Gan Huang, Yaxi Zhu, et al.
Diabetologia|December 14, 2020
Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analysesNatalie Nanayakkara, Andrea J Curtis, Stephane Heritier, et al.
The Lancet. Diabetes & Endocrinology|June 24, 2025
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialLinong Ji, Leili Gao, Haibo Xue, et al.
Pageof 59